Literature DB >> 17279411

Reconstruction of bone defects with impacted allograft in femoral stem revision surgery.

Alberto Francés1, Enrique Moro, Juan-Luis Cebrian, Fernando Marco, Antonio García-López, David Serfaty, Luis López-Durán.   

Abstract

A retrospective clinical review was done on 54 revision hip patients. Radiological analysis examined the Gross and AAOS classifications, stem position, cement mantles, allograft and evolution (subsidence, resorption and remodelling). The Harris Hip score was used for clinical assessment. We used bone bank allograft and a polished non-collared stem LD. The follow-up period was 60.5 months (19.4-152.4), and the average age 68.5 (range: 22-85). There were 21 females and 33 males. The surgical approach was: lateral (5.56%) posterior (91.4%); trochanteric osteotomy: 25.9%; associated acetabular revision: 59.3%; previous operations: 1.9. The preoperative Harris score was 35 (28-40) and rose to 81 (50-99) postoperatively. The stem alignment was neutral (44.44%), varus (38.89%) and valgus (16.67%). The femur/stem diameter relationship was 1.8 (1.2-2.7). There were no changes in stem alignment in 94.4%. An adequate cement mantle was: proximal zone (61.1%), medium zone (27.8%) and distal zone (16.7%). The rate of any subsidence was 38.9% (progressive: 12.96%). The rate of complications was 40.7% and included periprosthetic fracture: 14.8%; superficial infection: 1.9%; deep late infection: 1.9%; dislocation: 3.7%; heterotopic ossification: 13%. The rate of new stem revision was 16.6%. The clinical and radiological success rate was 77.78%. A greater incidence of revisions has been found in stem malalignment, progressive subsidence, a Harris increase of <20 points, allograft resorption, small diameter stems and inadequate cement mantle. We recommend hard impaction and a cement mantle of at least 2 mm. Non-progressive subsidence does not increase stem loosening. The technique has been useful in recovering bone stock in a severely defective femur and achieves a stable reconstruction. The level of evidence was therapeutic study level III-2 (retrospective cohort study; see the instructions to the authors for a complete description of the levels of evidence).

Entities:  

Mesh:

Year:  2007        PMID: 17279411      PMCID: PMC2267641          DOI: 10.1007/s00264-006-0211-y

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  22 in total

1.  Results of hip revision using the Exeter stem, impacted allograft bone, and cement.

Authors:  E Ornstein; I Atroshi; H Franzén; R Johnsson; P Sandquist; M Sundberg
Journal:  Clin Orthop Relat Res       Date:  2001-08       Impact factor: 4.176

2.  Histology of impacted bone-graft incorporation.

Authors:  G Ullmark; K J Obrant
Journal:  J Arthroplasty       Date:  2002-02       Impact factor: 4.757

3.  Impacted cancellous allografts and cement for revision total hip arthroplasty.

Authors:  G A Gie; L Linder; R S Ling; J P Simon; T J Slooff; A J Timperley
Journal:  J Bone Joint Surg Br       Date:  1993-01

4.  Contained morselized allograft in revision total hip arthroplasty. Surgical technique.

Authors:  G A Gie; L Linder; R S Ling; J P Simon; T J Slooff; A J Timperley
Journal:  Orthop Clin North Am       Date:  1993-10       Impact factor: 2.472

5.  Revision arthroplasty of the proximal femur using allograft bone.

Authors:  A E Gross; D G Allan; G J Lavoie; R D Oakeshott
Journal:  Orthop Clin North Am       Date:  1993-10       Impact factor: 2.472

6.  The biology of bone graft repair.

Authors:  H Burchardt
Journal:  Clin Orthop Relat Res       Date:  1983-04       Impact factor: 4.176

7.  Proximal femoral allografts for reconstruction of bone stock in revision arthroplasty of the hip. A nine to fifteen-year follow-up.

Authors:  H R Blackley; A M Davis; C R Hutchison; A E Gross
Journal:  J Bone Joint Surg Am       Date:  2001-03       Impact factor: 5.284

8.  Load-bearing increases new bone formation in impacted and morselized allografts.

Authors:  J S Wang; M Tägil; P Aspenberg
Journal:  Clin Orthop Relat Res       Date:  2000-09       Impact factor: 4.176

9.  Impaction bone grafting in revision hip surgery. A high incidence of complications.

Authors:  J Pekkarinen; A Alho; J Lepistö; M Ylikoski; P Ylinen; T Paavilainen
Journal:  J Bone Joint Surg Br       Date:  2000-01

10.  Impaction allografting with cement for revision of the femoral component. A minimum four-year follow-up study with use of a precoated femoral stem.

Authors:  S S Leopold; R A Berger; A G Rosenberg; J J Jacobs; L R Quigley; J O Galante
Journal:  J Bone Joint Surg Am       Date:  1999-08       Impact factor: 5.284

View more
  5 in total

1.  Three-dimensional virtual bone bank system for selecting massive bone allograft in orthopaedic oncology.

Authors:  Zhigang Wu; Jun Fu; Zhen Wang; Xiangdong Li; Jing Li; Yanjun Pei; Guoxian Pei; Dan Li; Zheng Guo; Hongbin Fan
Journal:  Int Orthop       Date:  2015-03-15       Impact factor: 3.075

2.  Biomechanical assays for the study of the effects of hip prostheses: application to the reconstruction of bone defects with femoral allografts.

Authors:  Alberto Francés; Rafael Claramunt; Juan-Luis Cebrian; Fernando Marco; Yaiza Lópiz; Ramon Muiña Rullanç; Antonio Ros; Luis López-Durán
Journal:  Musculoskelet Surg       Date:  2012-12-30

3.  The Modular Universal Tumour And Revision System (MUTARS®) in endoprosthetic revision surgery.

Authors:  Carsten Gebert; Martin Wessling; Christian Götze; Georg Gosheger; Jendrik Hardes
Journal:  Int Orthop       Date:  2010-04-09       Impact factor: 3.075

4.  Increased Risk of Heterotopic Ossification Following Revision Hip Arthroplasty for Periprosthetic Joint Infection.

Authors:  Jorge Manrique; Pouya Alijanipour; Snir Heller; Michael Dove; Javad Parvizi
Journal:  Arch Bone Jt Surg       Date:  2018-11

5.  Biological effects of rinsing morsellised bone grafts before and after impaction.

Authors:  Gerjon Hannink; Ester Piek; Jose M A Hendriks; Peter M Van der Kraan; B Willem Schreurs; Pieter Buma
Journal:  Int Orthop       Date:  2008-01-16       Impact factor: 3.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.